GSK2981278   

GtoPdb Ligand ID: 9661

Compound class: Synthetic organic
Comment: GSK2981278 is a potent and selective inverse agonist of the nuclear receptor retinoid-related orphan receptor, RORγ [2]. It has been investigated for anti-inflammatory potential.
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 84.45
Molecular weight 461.22
XLogP 4.91
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES OCc1cc(ccc1OCC1CCOCC1)S(=O)(=O)N(c1ccc(cc1)CC)CC(C)C
Isomeric SMILES OCc1cc(ccc1OCC1CCOCC1)S(=O)(=O)N(c1ccc(cc1)CC)CC(C)C
InChI InChI=1S/C25H35NO5S/c1-4-20-5-7-23(8-6-20)26(16-19(2)3)32(28,29)24-9-10-25(22(15-24)17-27)31-18-21-11-13-30-14-12-21/h5-10,15,19,21,27H,4,11-14,16-18H2,1-3H3
InChI Key LZLBRISQTJVZNP-UHFFFAOYSA-N
No information available.
Summary of Clinical Use
GSK2981278 has completed Phase 2 clinical trial (NCT03004846) in patients with plaque psoriasis.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03004846 A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis Phase 1/Phase 2 Interventional GlaxoSmithKline